Price-control measures such as the Most-Favored-Nation Drug Pricing policy can reduce access to new medicines, warns Canadian think tank MEIPharmaceutical innovation is responsible for up to 66% of the increase in the age of death in the United States, and 73% in 26 high-income countries
